[{"Assets_0_Q1_USD":19523000.0,"CommonStockSharesOutstanding_0_Q1_shares":17219300.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-604000.0,"NetIncomeLoss_1_Q1_USD":-1359000.0,"StockholdersEquity_0_Q1_USD":18553000.0,"Ticker":"SAVA","CIK":"1069530","name":"CASSAVA SCIENCES INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190502"}]